Groundbreaking Cancer screen test
A World First … a high-sensitivity cancer screening test arrives in SA.
![Medical 1](https://images.caxton.co.za/wp-content/uploads/sites/49/2022/02/medical-1-780x470.jpg)
With worldwide increase in the incidence of cancers, it is of utmost importance that a reliable, easy-to-access and affordable cancer screening test be used as part of annual health check by all individuals over 40 years of age. So excellent news that the blood-based Trucheck cancer screening test launches in South Africa today, World Cancer Day.
Single organ cancer screening tests, such as Trucheck–Breast and Trucheck–Prostate, can detect earliest traces of the respective cancers from a simple blood sample. This creates a reliable substitute to mammogram and digital prostatic examination. And the broader panel Trucheck–Intelli can screen for 70 different organ-specific tumours in a single test.
The high-accuracy test is much more reliable than commonly prevalent blood tests for health screening.
The developer, Datar Cancer Genetics Laboratory, is a world leader in the area of personalized cancer treatment and early detection of cancers, recently announced that the US Food and Drug Administration (FDA) had granted ‘Biological Breakthrough Device’ designation for its blood test to detect early-stage breast cancer, as early as stage 0.
Worldwide, breast cancer is detected in more than 2.3 million women each year. The objective of having early diagnoses of life-threatening diseases, such as cancer, is to ensure enhanced longevity, and even cure from cancers in many instances. Cancer survival rates dramatically increase from 22 per cent at late-stage diagnosis to more than 90 per cent in the case of early-stage diagnosis. Early detection of cancers also guarantees lesser expense on treatment.
The Trucheck Intelli test uses a proprietary technology to detect Circulating Tumor Cells (CTCs). Studies have shown that even Stage 0(DCIS) and Stage 1 cancers are detected with the highest accuracy through the test, which requires only 10ml of blood and can be used by any asymptomatic individual above the age of 40.
For more information about Unique Diagnostics and Datar Cancer Genetics, visit www.uniquediagnostics.co.za, or email info@uniquediagnostics.co.za.